Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma.

J Neurooncol · 2023 · PMC10522719 · PMID 37665475

Europe PMC DOI

hedged sentence

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

of borderline significancep = 0.088so close (0.05 < p ≤ 0.1)

≥40 years), site of disease, treatment volume, MGMT methylation status, RT techniques and dose did not affect survival; however, smaller treatment volume were of borderline significance ( p = 0.088).

also in 469 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.